Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Monomeric rhodium(II) catalysts for the preparation of aziridines and enantioselective formation of cyclopropanes from ethyl diazoacetate at room temperature.

The Journal of organic chemistry

Krumper JR, Gerisch M, Suh JM, Bergman RG, Tilley TD.
PMID: 14656097
J Org Chem. 2003 Dec 12;68(25):9705-10. doi: 10.1021/jo035120e.

A family of bis(oxazoline) complexes of coordinatively unsaturated monomeric rhodium(II) (2a,b, 3a,b) are described. These complexes serve as catalysts for cyclopropanation of olefins by ethyl diazoacetate, giving excellent yields (66-94%). Enantioselectivities for the cis product isomers are good (61-84%)....

Cite
Krumper JR, Gerisch M, Suh JM, et al. Monomeric rhodium(II) catalysts for the preparation of aziridines and enantioselective formation of cyclopropanes from ethyl diazoacetate at room temperature. J Org Chem. 2003;68(25):9705-10doi: 10.1021/jo035120e.
Krumper, J. R., Gerisch, M., Suh, J. M., Bergman, R. G., & Tilley, T. D. (2003). Monomeric rhodium(II) catalysts for the preparation of aziridines and enantioselective formation of cyclopropanes from ethyl diazoacetate at room temperature. The Journal of organic chemistry, 68(25), 9705-10. https://doi.org/10.1021/jo035120e
Krumper, J R, et al. "Monomeric rhodium(II) catalysts for the preparation of aziridines and enantioselective formation of cyclopropanes from ethyl diazoacetate at room temperature." The Journal of organic chemistry vol. 68,25 (2003): 9705-10. doi: https://doi.org/10.1021/jo035120e
Krumper JR, Gerisch M, Suh JM, Bergman RG, Tilley TD. Monomeric rhodium(II) catalysts for the preparation of aziridines and enantioselective formation of cyclopropanes from ethyl diazoacetate at room temperature. J Org Chem. 2003 Dec 12;68(25):9705-10. doi: 10.1021/jo035120e. PMID: 14656097.
Copy Download .nbib Format: NLM
Habitat disturbance and hydrological parameters determine the body size and reproductive strategy of alluvial ground beetles.

ZooKeys

Gerisch M.
PMID: 21738421
Zookeys. 2011;(100):353-70. doi: 10.3897/zookeys.100.1427. Epub 2011 May 20.

Environmental variability is the main driver for the variation of biological characteristics (life-history traits) of species. Therefore, life-history traits are particularly suited to identify mechanistic linkages between environmental variability and species occurrence and can help in explaining ecological patterns....

Cite
Gerisch M. Habitat disturbance and hydrological parameters determine the body size and reproductive strategy of alluvial ground beetles. Zookeys. 2011;(100):353-70doi: 10.3897/zookeys.100.1427.
Gerisch, M. (2011). Habitat disturbance and hydrological parameters determine the body size and reproductive strategy of alluvial ground beetles. ZooKeys, (100), 353-70. https://doi.org/10.3897/zookeys.100.1427
Gerisch, Michael. "Habitat disturbance and hydrological parameters determine the body size and reproductive strategy of alluvial ground beetles." ZooKeys vol. ,100 (2011): 353-70. doi: https://doi.org/10.3897/zookeys.100.1427
Gerisch M. Habitat disturbance and hydrological parameters determine the body size and reproductive strategy of alluvial ground beetles. Zookeys. 2011;(100):353-70. doi: 10.3897/zookeys.100.1427. Epub 2011 May 20. PMID: 21738421; PMCID: PMC3131025.
Copy Download .nbib Format: NLM
Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy.

Frontiers in genetics

Gerisch M, Smettan J, Ebert S, Athelogou M, Brand-Saberi B, Spindler N, Mueller WC, Giri S, Bader A.
PMID: 29559994
Front Genet. 2018 Mar 06;9:72. doi: 10.3389/fgene.2018.00072. eCollection 2018.

We aimed to identify and quantify CD117

Cite
Gerisch M, Smettan J, Ebert S, et al. Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. Front Genet. 2018;9:72doi: 10.3389/fgene.2018.00072.
Gerisch, M., Smettan, J., Ebert, S., Athelogou, M., Brand-Saberi, B., Spindler, N., Mueller, W. C., Giri, S., & Bader, A. (2018). Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. Frontiers in genetics, 972. https://doi.org/10.3389/fgene.2018.00072
Gerisch, Marie, et al. "Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy." Frontiers in genetics vol. 9 (2018): 72. doi: https://doi.org/10.3389/fgene.2018.00072
Gerisch M, Smettan J, Ebert S, Athelogou M, Brand-Saberi B, Spindler N, Mueller WC, Giri S, Bader A. Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. Front Genet. 2018 Mar 06;9:72. doi: 10.3389/fgene.2018.00072. eCollection 2018. PMID: 29559994; PMCID: PMC5845648.
Copy Download .nbib Format: NLM
Atrial Fibrillation in Obstructive Hypertrophic Cardiomyopathy: Seek, Find and Treat.

The Annals of thoracic surgery

Gerdisch MW.
PMID: 34780764
Ann Thorac Surg. 2021 Nov 12; doi: 10.1016/j.athoracsur.2021.09.075. Epub 2021 Nov 12.

No abstract available.

Cite
Gerdisch MW. Atrial Fibrillation in Obstructive Hypertrophic Cardiomyopathy: Seek, Find and Treat. Ann Thorac Surg. 2021;doi: 10.1016/j.athoracsur.2021.09.075.
Gerdisch, M. W. (2021). Atrial Fibrillation in Obstructive Hypertrophic Cardiomyopathy: Seek, Find and Treat. The Annals of thoracic surgery, . https://doi.org/10.1016/j.athoracsur.2021.09.075
Gerdisch, Marc W. "Atrial Fibrillation in Obstructive Hypertrophic Cardiomyopathy: Seek, Find and Treat." The Annals of thoracic surgery vol. (2021). doi: https://doi.org/10.1016/j.athoracsur.2021.09.075
Gerdisch MW. Atrial Fibrillation in Obstructive Hypertrophic Cardiomyopathy: Seek, Find and Treat. Ann Thorac Surg. 2021 Nov 12; doi: 10.1016/j.athoracsur.2021.09.075. Epub 2021 Nov 12. PMID: 34780764.
Copy Download .nbib Format: NLM
Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume.

Biomedicines

Nelissen E, Argyrousi EK, Van Goethem NP, Zhao F, Hines CDG, Swaminath G, Gerisch M, Hueser J, Sandner P, Prickaerts J.
PMID: 34440254
Biomedicines. 2021 Aug 19;9(8). doi: 10.3390/biomedicines9081047.

Vascular cognitive impairment (VCI) is characterized by impairments in cerebral blood flow (CBF), endothelial function and blood-brain barrier (BBB) integrity. These processes are all physiologically regulated by the nitric oxide (NO)-soluble guanylate cyclase (sGC)-cGMP signaling pathway. Additionally, cGMP signaling...

Cite
Nelissen E, Argyrousi EK, Van Goethem NP, et al. Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume. Biomedicines. 2021;9(8)doi: 10.3390/biomedicines9081047.
Nelissen, E., Argyrousi, E. K., Van Goethem, N. P., Zhao, F., Hines, C. D. G., Swaminath, G., Gerisch, M., Hueser, J., Sandner, P., & Prickaerts, J. (2021). Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume. Biomedicines, 9(8), . https://doi.org/10.3390/biomedicines9081047
Nelissen, Ellis, et al. "Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume." Biomedicines vol. 9,8 (2021). doi: https://doi.org/10.3390/biomedicines9081047
Nelissen E, Argyrousi EK, Van Goethem NP, Zhao F, Hines CDG, Swaminath G, Gerisch M, Hueser J, Sandner P, Prickaerts J. Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume. Biomedicines. 2021 Aug 19;9(8). doi: 10.3390/biomedicines9081047. PMID: 34440254; PMCID: PMC8393324.
Copy Download .nbib Format: NLM
Aortic valve repair for tri-leaflet aortic insufficiency associated with asymmetric aortic root aneurysms.

Annals of cardiothoracic surgery

Stavridis GT, Downey RS, Gerdisch MW, Hughes GC, Jasinski MJ, Rankin JS, Mazzitelli D, Aicher D, Fischlein T, Choi YH, Weber A, Friedrich I, Glauber M, Pfeiffer S, Miceli A, Si MS, Klokocovnik T, Wei LM, Deja MA, Badhwar V.
PMID: 31240192
Ann Cardiothorac Surg. 2019 May;8(3):426-429. doi: 10.21037/acs.2019.04.10.

No abstract available.

Cite
Stavridis GT, Downey RS, Gerdisch MW, et al. Aortic valve repair for tri-leaflet aortic insufficiency associated with asymmetric aortic root aneurysms. Ann Cardiothorac Surg. 2019;8(3):426-429doi: 10.21037/acs.2019.04.10.
Stavridis, G. T., Downey, R. S., Gerdisch, M. W., Hughes, G. C., Jasinski, M. J., Rankin, J. S., Mazzitelli, D., Aicher, D., Fischlein, T., Choi, Y. H., Weber, A., Friedrich, I., Glauber, M., Pfeiffer, S., Miceli, A., Si, M. S., Klokocovnik, T., Wei, L. M., Deja, M. A., & Badhwar, V. (2019). Aortic valve repair for tri-leaflet aortic insufficiency associated with asymmetric aortic root aneurysms. Annals of cardiothoracic surgery, 8(3), 426-429. https://doi.org/10.21037/acs.2019.04.10
Stavridis, George T, et al. "Aortic valve repair for tri-leaflet aortic insufficiency associated with asymmetric aortic root aneurysms." Annals of cardiothoracic surgery vol. 8,3 (2019): 426-429. doi: https://doi.org/10.21037/acs.2019.04.10
Stavridis GT, Downey RS, Gerdisch MW, Hughes GC, Jasinski MJ, Rankin JS, Mazzitelli D, Aicher D, Fischlein T, Choi YH, Weber A, Friedrich I, Glauber M, Pfeiffer S, Miceli A, Si MS, Klokocovnik T, Wei LM, Deja MA, Badhwar V. Aortic valve repair for tri-leaflet aortic insufficiency associated with asymmetric aortic root aneurysms. Ann Cardiothorac Surg. 2019 May;8(3):426-429. doi: 10.21037/acs.2019.04.10. PMID: 31240192; PMCID: PMC6562090.
Copy Download .nbib Format: NLM
Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial.

The Journal of thoracic and cardiovascular surgery

McCarthy PM, Gerdisch M, Philpott J, Barnhart GR, Waldo AL, Shemin R, Andrei AC, Gaynor S, Ndikintum N, Calkins H.
PMID: 33129501
J Thorac Cardiovasc Surg. 2020 Oct 03; doi: 10.1016/j.jtcvs.2020.09.099. Epub 2020 Oct 03.

OBJECTIVES: The Cox Maze IV operation is commonly performed concomitant with other cardiac operations and effectively reduces the burden of atrial fibrillation. Prospective randomized trials have reported outcomes early and at 12 months, but only single-center late durability results...

Cite
McCarthy PM, Gerdisch M, Philpott J, et al. Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial. J Thorac Cardiovasc Surg. 2020;doi: 10.1016/j.jtcvs.2020.09.099.
McCarthy, P. M., Gerdisch, M., Philpott, J., Barnhart, G. R., Waldo, A. L., Shemin, R., Andrei, A. C., Gaynor, S., Ndikintum, N., & Calkins, H. (2020). Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2020.09.099
McCarthy, Patrick M, et al. "Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial." The Journal of thoracic and cardiovascular surgery vol. (2020). doi: https://doi.org/10.1016/j.jtcvs.2020.09.099
McCarthy PM, Gerdisch M, Philpott J, Barnhart GR, Waldo AL, Shemin R, Andrei AC, Gaynor S, Ndikintum N, Calkins H. Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial. J Thorac Cardiovasc Surg. 2020 Oct 03; doi: 10.1016/j.jtcvs.2020.09.099. Epub 2020 Oct 03. PMID: 33129501.
Copy Download .nbib Format: NLM
Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone.

CPT: pharmacometrics & systems pharmacology

Wendl T, Frechen S, Gerisch M, Heinig R, Eissing T.
PMID: 34783193
CPT Pharmacometrics Syst Pharmacol. 2021 Nov 15; doi: 10.1002/psp4.12746. Epub 2021 Nov 15.

Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist that recently demonstrated its efficacy to delay chronic kidney disease (CKD) progression and reduce cardiovascular events in patients with CKD and type 2 diabetes. Here, we report the development of a...

Cite
Wendl T, Frechen S, Gerisch M, et al. Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone. CPT Pharmacometrics Syst Pharmacol. 2021;doi: 10.1002/psp4.12746.
Wendl, T., Frechen, S., Gerisch, M., Heinig, R., & Eissing, T. (2021). Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone. CPT: pharmacometrics & systems pharmacology, . https://doi.org/10.1002/psp4.12746
Wendl, Thomas, et al. "Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone." CPT: pharmacometrics & systems pharmacology vol. (2021). doi: https://doi.org/10.1002/psp4.12746
Wendl T, Frechen S, Gerisch M, Heinig R, Eissing T. Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone. CPT Pharmacometrics Syst Pharmacol. 2021 Nov 15; doi: 10.1002/psp4.12746. Epub 2021 Nov 15. PMID: 34783193.
Copy Download .nbib Format: NLM
Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement.

Innovations (Philadelphia, Pa.)

Gerdisch MW, Akinwande AO, Matheny RG.
PMID: 22437278
Innovations (Phila). 2010 Jan;5(1):60-2. doi: 10.1097/IMI.0b013e3181cbb421.

A patient with a history of aortic valve endocarditis and surgical debridement presented with acute congestive heart failure because of severe aortic stenosis. During valve replacement surgery, an aortic annular enlargement was required to overcome a potential patient-prosthesis mismatch....

Cite
Gerdisch MW, Akinwande AO, Matheny RG. Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement. Innovations (Phila). 2010;5(1):60-2doi: 10.1097/IMI.0b013e3181cbb421.
Gerdisch, M. W., Akinwande, A. O., & Matheny, R. G. (2010). Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement. Innovations (Philadelphia, Pa.), 5(1), 60-2. https://doi.org/10.1097/IMI.0b013e3181cbb421
Gerdisch, Marc W, et al. "Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement." Innovations (Philadelphia, Pa.) vol. 5,1 (2010): 60-2. doi: https://doi.org/10.1097/IMI.0b013e3181cbb421
Gerdisch MW, Akinwande AO, Matheny RG. Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement. Innovations (Phila). 2010 Jan;5(1):60-2. doi: 10.1097/IMI.0b013e3181cbb421. PMID: 22437278.
Copy Download .nbib Format: NLM
Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement.

Innovations (Philadelphia, Pa.)

Gerdisch MW, Akinwande AO, Matheny RG.
PMID: 22437278
Innovations (Phila). 2010 Jan;5(1):60-2. doi: 10.1097/IMI.0b013e3181cbb421.

A patient with a history of aortic valve endocarditis and surgical debridement presented with acute congestive heart failure because of severe aortic stenosis. During valve replacement surgery, an aortic annular enlargement was required to overcome a potential patient-prosthesis mismatch....

Cite
Gerdisch MW, Akinwande AO, Matheny RG. Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement. Innovations (Phila). 2010;5(1):60-2doi: 10.1097/IMI.0b013e3181cbb421.
Gerdisch, M. W., Akinwande, A. O., & Matheny, R. G. (2010). Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement. Innovations (Philadelphia, Pa.), 5(1), 60-2. https://doi.org/10.1097/IMI.0b013e3181cbb421
Gerdisch, Marc W, et al. "Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement." Innovations (Philadelphia, Pa.) vol. 5,1 (2010): 60-2. doi: https://doi.org/10.1097/IMI.0b013e3181cbb421
Gerdisch MW, Akinwande AO, Matheny RG. Use of a novel acellular xenograft as a patch for aortic annular enlargement during aortic valve replacement. Innovations (Phila). 2010 Jan;5(1):60-2. doi: 10.1097/IMI.0b013e3181cbb421. PMID: 22437278.
Copy Download .nbib Format: NLM
Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage.

Annals of cardiothoracic surgery

Allen KB, Icke KJ, Thourani VH, Naka Y, Grubb KJ, Grehan J, Patel N, Guy TS, Landolfo K, Gerdisch M, Bonnell M.
PMID: 30505745
Ann Cardiothorac Surg. 2018 Sep;7(5):611-620. doi: 10.21037/acs.2018.06.01.

BACKGROUND: Rigid plate fixation (RPF) is the cornerstone in managing fractures and osteotomies except for sternotomy, where most cardiac surgeons continue to use wire cerclage (WC). Results of a multicenter randomized trial evaluating sternal healing, sternal complications, patient reported...

Cite
Allen KB, Icke KJ, Thourani VH, et al. Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage. Ann Cardiothorac Surg. 2018;7(5):611-620doi: 10.21037/acs.2018.06.01.
Allen, K. B., Icke, K. J., Thourani, V. H., Naka, Y., Grubb, K. J., Grehan, J., Patel, N., Guy, T. S., Landolfo, K., Gerdisch, M., & Bonnell, M. (2018). Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage. Annals of cardiothoracic surgery, 7(5), 611-620. https://doi.org/10.21037/acs.2018.06.01
Allen, Keith B, et al. "Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage." Annals of cardiothoracic surgery vol. 7,5 (2018): 611-620. doi: https://doi.org/10.21037/acs.2018.06.01
Allen KB, Icke KJ, Thourani VH, Naka Y, Grubb KJ, Grehan J, Patel N, Guy TS, Landolfo K, Gerdisch M, Bonnell M. Sternotomy closure using rigid plate fixation: a paradigm shift from wire cerclage. Ann Cardiothorac Surg. 2018 Sep;7(5):611-620. doi: 10.21037/acs.2018.06.01. PMID: 30505745; PMCID: PMC6219953.
Copy Download .nbib Format: NLM
Novel bis(oxazoline) pincer ligands: formation of mononuclear rhodium(II) complexes.

Journal of the American Chemical Society

Gerisch M, Krumper JR, Bergman RG, Tilley TD.
PMID: 11403623
J Am Chem Soc. 2001 Jun 20;123(24):5818-9. doi: 10.1021/ja005857a.

No abstract available.

Cite
Gerisch M, Krumper JR, Bergman RG, et al. Novel bis(oxazoline) pincer ligands: formation of mononuclear rhodium(II) complexes. J Am Chem Soc. 2001;123(24):5818-9doi: 10.1021/ja005857a.
Gerisch, M., Krumper, J. R., Bergman, R. G., & Tilley, T. D. (2001). Novel bis(oxazoline) pincer ligands: formation of mononuclear rhodium(II) complexes. Journal of the American Chemical Society, 123(24), 5818-9. https://doi.org/10.1021/ja005857a
Gerisch, M, et al. "Novel bis(oxazoline) pincer ligands: formation of mononuclear rhodium(II) complexes." Journal of the American Chemical Society vol. 123,24 (2001): 5818-9. doi: https://doi.org/10.1021/ja005857a
Gerisch M, Krumper JR, Bergman RG, Tilley TD. Novel bis(oxazoline) pincer ligands: formation of mononuclear rhodium(II) complexes. J Am Chem Soc. 2001 Jun 20;123(24):5818-9. doi: 10.1021/ja005857a. PMID: 11403623.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries